Tagged: AIDS

  • Shaping the world we want to live in

    As FHI 360 marks its 50th anniversary, explore our history of solutions and future of possibilities. 

    Dr. Timothy Mastro, FHI 360’s Chief Science Officer, offers his perspective on where we’ve been, where we’re going and what’s at stake in human development.

    Continue reading

    FHI 360 at 50: Setting the stage for health solutions that improve and save lives

    As FHI 360 marks its 50th anniversary, explore our history of solutions and future of possibilities. 

    In 1999, AIDS was the fourth biggest cause of death worldwide. And, it was the number one killer in Africa.

    Continue reading

  • How to prevent illness and death caused by tuberculosis among people living with HIV

    The global health community is concerned that tuberculosis (TB) continues to disproportionately kill people living with HIV, despite the availability of TB preventive therapy. According to the World Health Organization’s Global Tuberculosis Report 2019, deaths attributed to TB among people living with HIV account for 17 percent of all TB deaths, even though people living with HIV account for only 8.6 percent of overall TB cases.

    Continue reading

  • New journal supplement on key populations is here!

    A version of this post originally appeared on the LINKAGES blog. Reprinted with permission.

    JIAS July 2018 issue coverThe USAID– and PEPFAR-supported LINKAGES project is excited to announce the arrival of a new supplement in the Journal of the International AIDS Society (JIAS) titled Optimizing the Impact of Key Population Programming Across the HIV Cascade.

    A collaboration among LINKAGES, USAID, CDC, amfAR, and JIAS, this supplement contributes new evidence and data-driven strategies for improving programming with men who have sex with men, sex workers, transgender people and people who inject drugs. It contains 14 original articles that represent a range of multidisciplinary efforts from diverse geographies to advance key population science and practice across the HIV prevention, care and treatment cascade.

    As HIV services are scaled up in pursuit of 90-90-90 targets, investments to address the epidemic among key populations must be central to these efforts. Global data indicate that gains made among key populations lag substantially behind those made in the general population. This supplement aims to accelerate progress toward controlling the epidemic by bringing visibility to new evidence and approaches that can make key population programming smarter and more effective.

    Continue reading

  • A future without AIDS begins and ends with key populations

    A version of this post originally appeared on the LINKAGES blog. Reprinted with permission.

    “We will only achieve HIV/AIDS epidemic control if we reach the UNAIDS 90-90-90 targets for all ages, genders, and at-risk groups, including key populations.”

    – Ambassador Deborah L. Birx, MD, U.S. Global AIDS Coordinator and U.S. Special Representative for Global Health Diplomacy, June 2018

    In 2013, UNAIDS set out to establish new global targets for HIV testing, care and treatment. Stakeholder consultations were conducted at country and regional levels around the world, ultimately resulting in the creation of the ambitious 90-90-90 targets to help bring an end to the AIDS epidemic:

    Continue reading

  • Achieving HIV epidemic control: Going the last mile and beyond

    The focus of the global effort to end the HIV/AIDS epidemic, now 37 years on, is epidemic control, which the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) defines as limiting the annual number of new HIV infections in a country to less than the number of deaths among people living with HIV.

    Sub-Saharan Africa, home to 26 million (70 percent) of the global total of 36.9 million people living with HIV, is where the battle must be won. To succeed and sustain the gains achieved in the past 15 years, countries in Africa will need to assume greater responsibility for managing their epidemics.

    Continue reading

  • It is time for a bold approach to end the HIV epidemic

    Big breakthroughs in HIV science, such as antiretroviral therapy and the “universal test and treat” policy, create hope and galvanize efforts to bring the epidemic to an end. Yet, no matter how promising the strategy, we know from experience that it is not easy to incorporate the latest approaches into poorly resourced, over-stretched health systems. Nor is it reasonable to expect that health systems can absorb the increased volume of patients that seems to go hand in hand with innovations.

    Continue reading

  • Three ways to turn science into practice to reduce HIV among key populations

    Later this month, leading scientists and cutting-edge thinkers will gather at the International AIDS Society’s 9th IAS Conference on HIV Science in Paris to discuss the latest scientific discoveries in HIV prevention, care and treatment. These discoveries hold the potential to accelerate progress toward the global 90-90-90 targets set forth by the Joint United Nations Programme on HIV/AIDS (UNAIDS). And, they are especially important for key populations — including men who have sex with men, sex workers, transgender people and people who inject drugs — who shoulder a disproportionate burden of HIV. UNAIDS estimates that 45 percent of all new HIV infections among adults worldwide occur among these key populations and their sex partners. Reaching these groups with new technologies and approaches is essential to ending the epidemic.

    Continue reading

  • Every year, the International AIDS Society (IAS) holds the largest open scientific conference on HIV and AIDS-related issues. This year’s conference, IAS 2017, will take place in July in Paris. FHI 360 is a media partner with IAS 2017, and in the lead-up to this year’s conference, we are coordinating Facebook Live conversations with experts who will be speaking there.

    One U.S. expert who will present at the conference is Dr. Anthony Fauci, Director of the U.S. National Institute of Allergy and Infectious Diseases. Dr. Fauci was recently in Washington, DC, to speak at the annual meeting of the HIV Prevention Trials Network. After his plenary talk, Dr. Fauci sat down with FHI 360’s Dr. Otto Chabikuli, Director of Global Health, Population and Nutrition, for a Facebook Live chat on the science of HIV. Dr. Fauci talked about his experience working in HIV research for more than 35 years, addressing issues such as what a cure for HIV might look like, the multiple ways to prevent HIV infection, treatment as prevention, and the projects that his team is currently working on.

    Continue reading

  • Keeping girls in school in Malawi means better health and a brighter future

    Mary Mittochi

    Photo: Ed Scholl/FHI 360

    In this Q&A, Mary Mittochi, the project director for DREAMS: Malawi Communities Investing in Education for Child Health and Safety, discusses how this new project will reduce the acquisition of HIV by adolescent girls and boys. The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) named FHI 360 as one of the winners of the DREAMS Innovation Challenge. The DREAMS partnership, led by PEPFAR with support from the Bill & Melinda Gates Foundation, Girl Effect, Johnson & Johnson, Gilead Sciences and ViiV Healthcare, is helping adolescent girls and young women become Determined, Resilient, Empowered, AIDS-free, Mentored and Safe.

    As one of the 56 DREAMS Innovation Challenge winners, how will FHI 360 help adolescent girls and young women become Determined, Resilient, Empowered, AIDS-free, Mentored and Safe?
    FHI 360’s DREAMS: Malawi Communities Investing in Education for Child Health and Safety project will focus on integrated, community-led efforts designed to ensure that education, health and economic drivers for staying in school and completing secondary education are simultaneously addressed and strengthened. Over time, this will reduce the incidence of HIV in adolescent girls and boys. By keeping girls in school and connecting them to a comprehensive range of services and supports, we aim to equip them and their communities with the knowledge and agency they need to make more informed choices about their health and their future.

    Continue reading